Showing 1 - 5 results of 5 for search 'Reto Thoma', query time: 0.03s Refine Results
  1. 1
    Ward-level risk factors associated with nosocomial coronavirus disease 2019 (COVID-19) outbreaks: A matched case–control study

    Ward-level risk factors associated with nosocomial coronavirus disease 2019 (COVID-19) outbreaks: A matched case–control study by Reto Thoma, Philipp Kohler, Sabine Haller, Jasmin Maenner, Matthias Schlegel, Domenica Flury

    Published 2022-01-01
    Get full text
    Article
  2. 2
    The challenge of preventing and containing outbreaks of multidrug-resistant organisms and Candida auris during the coronavirus disease 2019 pandemic: report of a carbapenem-resistant Acinetobacter baumannii outbreak and a systematic review of the literature

    The challenge of preventing and containing outbreaks of multidrug-resistant organisms and Candida auris during the coronavirus disease 2019 pandemic: report of a carbapenem-resista... by Reto Thoma, Marco Seneghini, Salomé N. Seiffert, Danielle Vuichard Gysin, Giulia Scanferla, Sabine Haller, Domenica Flury, Katia Boggian, Gian-Reto Kleger, Miodrag Filipovic, Oliver Nolte, Matthias Schlegel, Philipp Kohler

    Published 2022-01-01
    Get full text
    Article
  3. 3
    Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19)

    Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study pro... by Pascal Urwyler, Panteleimon Charitos, Stephan Moser, Ingmar A. F. M. Heijnen, Marten Trendelenburg, Reto Thoma, Johannes Sumer, Adrián Camacho-Ortiz, Marcelo R. Bacci, Lars C. Huber, Melina Stüssi-Helbling, Werner C. Albrich, Parham Sendi, Michael Osthoff

    Published 2021-01-01
    Get full text
    Article
  4. 4
    Recombinant C1 inhibitor in the prevention of severe COVID-19: a randomized, open-label, multi-center phase IIa trial

    Recombinant C1 inhibitor in the prevention of severe COVID-19: a randomized, open-label, multi-center phase IIa trial by Pascal Urwyler, Marina Leimbacher, Panteleimon Charitos, Stephan Moser, Ingmar A. F. M. Heijnen, Marten Trendelenburg, Marten Trendelenburg, Marten Trendelenburg, Reto Thoma, Johannes Sumer, Adrián Camacho-Ortiz, Marcelo R. Bacci, Lars C. Huber, Melina Stüssi-Helbling, Werner C. Albrich, Parham Sendi, Michael Osthoff, Michael Osthoff, Michael Osthoff

    Published 2023-10-01
    Get full text
    Article
  5. 5
    Impact of respirator versus surgical masks on SARS-CoV-2 acquisition in healthcare workers: a prospective multicentre cohort

    Impact of respirator versus surgical masks on SARS-CoV-2 acquisition in healthcare workers: a prospective multicentre cohort by Sabine Haller, Sabine Güsewell, Thomas Egger, Giulia Scanferla, Reto Thoma, Onicio B. Leal-Neto, Domenica Flury, Angela Brucher, Eva Lemmenmeier, J. Carsten Möller, Philip Rieder, Markus Rütti, Reto Stocker, Danielle Vuichard-Gysin, Benedikt Wiggli, Ulrike Besold, Stefan P. Kuster, Allison McGeer, Lorenz Risch, Matthias Schlegel, Andrée Friedl, Pietro Vernazza, Christian R. Kahlert, Philipp Kohler

    Published 2022-02-01
    Get full text
    Article

Search Tools: